CN1057935C - Chinese medicinal powder preparation for treating hepatocirrhosis - Google Patents
Chinese medicinal powder preparation for treating hepatocirrhosis Download PDFInfo
- Publication number
- CN1057935C CN1057935C CN98112259A CN98112259A CN1057935C CN 1057935 C CN1057935 C CN 1057935C CN 98112259 A CN98112259 A CN 98112259A CN 98112259 A CN98112259 A CN 98112259A CN 1057935 C CN1057935 C CN 1057935C
- Authority
- CN
- China
- Prior art keywords
- radix
- fructus
- rhizoma
- grams
- liver cirrhosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The present invention relates to a Chinese medicinal powder preparation for curing liver cirrhosis, which is suitable for curing patients with liver cirrhosis and hepatic hydroperitoneum. The preparation is mainly prepared from various Chinese medicinal herbs and can quickly and thoroughly cure liver cirrhosis. A result of clinical application indicates that all patients in each period of liver cirrhosis and hepatic hydroperitoneum can obtain a satisfactory curative effect after administering the preparation for a plurality of months. In addition, Chinese medicinal herbs are used as components of the Chinese medicinal powder preparation provided by the present invention, and the working process is simple. Thereby, the present invention has the advantages of easy preparation and no toxic or side effect on a human body.
Description
The present invention relates to a kind of Chinese powder medicine for the treatment of liver cirrhosis.Be applicable to treatment to liver cirrhosis and liver cirrhosis later stage patients with ascites.
China is a hepatopathy big country, only hepatitis B patient just accounts for 2/3rds of such patient's sum of the world, and according to national health department's conservative estimation, China's chronic viral hepatitis B virus carrier is more than 1.2 hundred million, by hepatitis B PD rule, wherein 10% hepatitis B virus carriers can be converted into liver cirrhosis.Therefore, only the patient with liver cirrhosis due to the hepatitis B is just about 1,200 ten thousand, and this does not also comprise third, the patient with liver cirrhosis due to fourth, hepatitis E and ethanol medicine etc.But the treatment in present stage to liver cirrhosis to the treatment of cirrhotic ascites, is a blank out at pharmaceutical preparations basically especially.And clinically this type of treatment of conditions is adopted the human albumin more now, but just be used to improve plasma osmotic pressure, be the fibrosis problem and can not really solve the liver sclerosis.
The purpose of this invention is to provide a kind of Chinese powder medicine of liver cirrhosis for the treatment of rapidly and thoroughly to remedy the deficiency of prior art.
The object of the present invention is achieved like this: a kind of Chinese powder medicine for the treatment of liver cirrhosis is characterized in that: press the solid weight ratio, wherein contain Rhizoma Atractylodis Macrocephalae 0.5%-2%, Herba Artemisiae Scopariae 2%-2.8%, Radix Et Rhizoma Rhei 0.5%-2%, five tastes 1%-1.6%, Herba Hedyotidis Diffusae 2%-2.8%, Poria skin 1%-1.6%, Radix Paeoniae Alba 2%-2.8%, Radix Bupleuri 0.3%-0.8%, Herba Lysimachiae 2%-2.8%, Semen Arecae 2%-2.8%, Radix Salviae Miltiorrhizae 2%-2.8%, Fructus Aurantii Immaturus 4%-5.6%, Cortex Magnoliae Officinalis 4%-5.6%, Semen Plantaginis 4%-5.6%, Polyporus 2%-2.8%, Rhizoma Polygoni Cuspidati 2%-2.8%, Rhizoma Alismatis 1%-1.6%, Herba Ecliptae 1%-1.6%, Radix Polygoni Multiflori 2%-2.8%, art 6%-12%, rhizoma sparganic 6%-12%, Fructus Crataegi 2%-2.8%, Massa Medicata Fermentata 2%-2 8%, Fructus Hordei Germinatus 2%-2.8%, Fructus Setariae Germinatus 2%-2.8%, Fructus Gardeniae 1%-1.6%, Radix Paeoniae Rubra 2%-3.8%, Radix Glehniae 4%-5.6%, Radix Notoginseng 1%-3%, Sanguis Draxonis 0.5%-1%, Fructus Ligustri Lucidi 1%-1.6%, ground beetle 4%-5.6%, Cortex Phellodendri 2%-2.8%.
Chinese powder medicine provided by the present invention, the result shows by clinical practice: to the compensatory cirrhosis patient of ascites not, take this product after 4 months, the normal effective percentage of liver function is about 95%; Harden early stage hepatic ascites three months with interior patient to losing the compensatory phase, take this product 5-6 month after, the normal effective percentage of liver function is about 80%; To losing the patient of compensatory phase sclerosis middle and advanced stage hepatic ascites more than three months, take this product 6-8 after individual month, the normal effective percentage of liver function is about 60%.Chinese powder medicine provided by the invention in addition, its component adopts common Chinese herbal medicine entirely, and manufacturing procedure is also simple, makes this product not only prepare easily, nor can produce toxic and side effects to human body.
Below by embodiment the present invention is further described:
Buy following Chinese herbal medicine earlier in the common Chinese shop: the Rhizoma Atractylodis Macrocephalae 20 grams, Herba Artemisiae Scopariae 40 grams, Radix Et Rhizoma Rhei 20 grams, the five tastes 20 grams, Herba Hedyotidis Diffusae 40 grams, Poria skin 20 grams, the Radix Paeoniae Alba 40 grams, Radix Bupleuri 10 grams, Herba Lysimachiae 40 grams, Semen Arecae 40 grams, Radix Salviae Miltiorrhizae 40 grams, Fructus Aurantii Immaturus 80 grams, Cortex Magnoliae Officinalis 80 grams, Semen Plantaginis 80 grams, Polyporus 40 grams, Rhizoma Polygoni Cuspidati 40 grams, Rhizoma Alismatis 20 grams, Herba Ecliptae 20 grams, Radix Polygoni Multiflori 40 grams, Rhizoma Curcumae 150 grams, rhizoma sparganic 150 grams, Fructus Crataegi 40 grams, Massa Medicata Fermentata 40 grams, Fructus Hordei Germinatus 40 grams, Fructus Setariae Germinatus 40 grams, Fructus Gardeniae 20 grams, Radix Paeoniae Rubra 50 grams, Radix Glehniae 80 grams, Radix Notoginseng 40 grams, Sanguis Draxonis 10 grams, Fructus Ligustri Lucidi 20 grams, ground beetle 80 grams, Cortex Phellodendri 40 grams.Then above-mentioned Chinese medicine is put into baking box and toast, wait Chinese medicine to be dried the back and take out, mix again, put into then and take out after pulverizer is ground into 140 order fine powders with it, promptly make finished product.
During use,, take this product gram every days 7, every day three times to the patient of liver cirrhosis and ascites.At the patient of different times, Time of Administration is different: to the compensatory cirrhosis patient of ascites not, took this product 4 months; Harden early stage hepatic ascites three months with interior patient to losing the compensatory phase, took this product 5-6 month; To losing the patient of compensatory phase sclerosis middle and advanced stage hepatic ascites more than three months, took this product 6-8 month.All can obtain satisfied effect.
Claims (1)
1, a kind of Chinese powder medicine for the treatment of liver cirrhosis, it is characterized in that: press the solid weight ratio, it is the Rhizoma Atractylodis Macrocephalae by 0.5%-2%, the Herba Artemisiae Scopariae of 2%-2.8%, the Radix Et Rhizoma Rhei of 0.5%-2%, the five tastes of 1%-1.6%, the Herba Hedyotidis Diffusae of 2%-2.8%, the Poria skin of 1%-1.6%, the Radix Paeoniae Alba of 2%-2.8%, the Radix Bupleuri of 0.3%-0.8%, the Herba Lysimachiae of 2%-2.8%, the Semen Arecae of 2%-2.8%, the Radix Salviae Miltiorrhizae of 2%-2.8%, the Fructus Aurantii Immaturus of 4%-5.6%, the Cortex Magnoliae Officinalis of 4%-5.6%, the Semen Plantaginis of 4%-5.6%, the Polyporus of 2%-2.8%, the Rhizoma Polygoni Cuspidati of 2%-2.8%, the Rhizoma Alismatis of 1%-1.6%, the Herba Ecliptae of 1%-1.6%, the Radix Polygoni Multiflori of 2%-2.8%, the Rhizoma Curcumae of 6%-12%, the rhizoma sparganic of 6%-12%, the Fructus Crataegi of 2%-2.8%, the Massa Medicata Fermentata of 2%-2.8%, the Fructus Hordei Germinatus of 2%-2.8%, the Fructus Setariae Germinatus of 2%-2.8%, the Fructus Gardeniae of 1%-1.6%, the Radix Paeoniae Rubra of 2%-3.8%, the Radix Glehniae of 4%-5.6%, the Radix Notoginseng of 1%-3%, the Sanguis Draxonis of 0.5%-1%, the Fructus Ligustri Lucidi of 1%-1.6%, the ground beetle of 4%-5.6%, the Cortex Phellodendri of 2%-2.8% is made.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN98112259A CN1057935C (en) | 1998-09-22 | 1998-09-22 | Chinese medicinal powder preparation for treating hepatocirrhosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN98112259A CN1057935C (en) | 1998-09-22 | 1998-09-22 | Chinese medicinal powder preparation for treating hepatocirrhosis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1211444A CN1211444A (en) | 1999-03-24 |
CN1057935C true CN1057935C (en) | 2000-11-01 |
Family
ID=5222129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN98112259A Expired - Fee Related CN1057935C (en) | 1998-09-22 | 1998-09-22 | Chinese medicinal powder preparation for treating hepatocirrhosis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1057935C (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1094057C (en) * | 1999-06-11 | 2002-11-13 | 钮自华 | Liver ascites treating medicine |
CN100345561C (en) * | 2003-04-08 | 2007-10-31 | 杨成山 | Chinese medicinal preparation for treating gallstone and its preparation method |
CN1326555C (en) * | 2005-04-29 | 2007-07-18 | 姜德连 | Chinese medicinal powder preparation for treating hepatic ascites |
CN104257848A (en) * | 2014-09-16 | 2015-01-07 | 赵金芝 | Traditional Chinese medicine for treating hepatic ascites |
CN104706775A (en) * | 2015-02-17 | 2015-06-17 | 聂玮 | Liver-nourishing kidney-tonifying traditional Chinese medicine composition for treating liver cirrhosis and preparation method of liver-nourishing and kidney-tonifying traditional Chinese medicine composition |
-
1998
- 1998-09-22 CN CN98112259A patent/CN1057935C/en not_active Expired - Fee Related
Non-Patent Citations (4)
Title |
---|
《中西医结合杂志》1988,8(4) 1988.4.30 傅静芬等,自拟中药为主治疗107例肝99后烃的疗效观察 * |
《中西医结合杂志》1988,8(4) 1988.4.30 傅静芬等,自拟中药为主治疗107例肝炎后肝硬变的疗效观察 * |
《吉林中医药》1995,(2) 1995.2.28 高秀真,强肝汤治疗肝硬化腹水40例临床观察 * |
《吉林中医药》1995,(2) 1995.2.28 高秀真,强肝汤治疗肝硬化腹水40例临床观察;《中西医结合杂志》1988,8(4) 1988.4.30 傅静芬等,自拟中药为主治疗107例肝炎后肝硬变的疗效观察;《中西医结合杂志》1988,8(4) 1988.4.30 傅静芬等,自拟中药为主治疗107例肝99后烃的疗效观察 * |
Also Published As
Publication number | Publication date |
---|---|
CN1211444A (en) | 1999-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6126942A (en) | Herbal compositions for hepatic disorders | |
CN101274044A (en) | Medicament for preventing and treating fatty liver and method of preparing the same | |
CN112891399A (en) | Traditional Chinese medicine composition and application and preparation method thereof | |
CN1891279A (en) | Capsule for treating cardio-cerebrovasular disease | |
CN101361946B (en) | Traditional Chinese medicine combination for treating hepatitis B | |
CN1057935C (en) | Chinese medicinal powder preparation for treating hepatocirrhosis | |
CN101293083B (en) | Pharmaceutical composition and preparation method thereof | |
CN1114206A (en) | Plaster for curing dysmenorrhea | |
CN1050046C (en) | Preparation method for medicine to cure flaccid paralysis | |
CN1557354A (en) | Chinese medicine aqueous pill preparation for treating hepatitis B and its preparation process | |
CN101757206A (en) | Chinese medicine preparation for treating chronic colitis | |
CN1056064C (en) | Medicine for curing liver cancer and its making method | |
CN1331996A (en) | Hepatitis B treaitng pill | |
CN1348789A (en) | Medicine for treating burns and scalds | |
CN104958662A (en) | Traditional Chinese medicinal composition for treating fatty liver hepatitis and hyperlipemia and preparation method thereof | |
CN1090183A (en) | Artemisia scoparia and ginseng pellet for mourishing liver and method for production thereof | |
CN101278982A (en) | Chinese medicine compound preparation for curing acute or chronic hepatitis B and method of preparing the same | |
CN100518800C (en) | Medicinal composition for treating hepatitis B | |
CN111000969A (en) | Pharmaceutical composition for treating simple obesity and preparation method thereof | |
CN104127602A (en) | Traditional Chinese medicine for treating fatty liver | |
CN101229291B (en) | Chinese traditional medicine composition for treating virus hepatitis by immunoregulation | |
CN1340353A (en) | Orally-applied medicine for treating hepatism and its preparing process | |
CN1098294A (en) | Manganning medicine | |
CN1332705C (en) | Chinese medicine for treating liver diseases | |
CN1206595A (en) | Thrombus dissolving Guiluchun |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |